4. Omar 2010.
Treatment Group | Control | P value | |
12 months follow‐up | |||
Randomised | 75 | 75 | — |
Completed | 60 | 63 | — |
Abnormal vaginal bleeding or spotting | 22 | 2 | <0.001 |
Breast cancer‐related deaths | 0 | 1 | NR |
24 months follow‐up | |||
Completed | 59 | 62 | — |
Abnormal vaginal bleeding or spotting | 7 | 2 | 0.08 |
Endometrial polyps | 1 | 10 | 0.02 |
Endometrial hyperplasia | 0 | 0 | NA |
Fibroids | 2 | 4 | 1.1 |
NA: not applicable NR: not reported